Medpro Pharmaceutica, a subsidiary company of Cipla Medpro, the third largest pharmaceutical company in South Africa, announced collaboration with Teva Pharmaceuticals, an affiliate of Teva Pharmaceutical Industries (Teva), the largest generic pharmaceutical manufacturer in the world.

Commenting on the same, Sarabjit Kour Nangra, VP Research, IT, Angel Broking, said, ''The collaboration is a sales and distribution arrangement whereby Cipla Medpro will exclusively market Teva’s broad pharmaceutical product portfolio in South Africa, with focus on therapeutic areas, such as oncology, central nervous system, women's health, cardiovascular, ophthalmology and other specialty products. This tie-up will fruther strengthen the company’s position in the South Africa. However, on back of the valuations, we remain neutral on the stock.''  

Disclaimer: IRIS has taken due care and caution in compilation of data for its web site. Information has been obtained by IRIS from sources which it considers reliable. However, IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website.